Digitisation | June 20, 2025
Healthcare Triangle launches Malaysian subsidiary QuantumNexis
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
Speakers for the session are: Dr. Richard Lobo, Global Head Business Excellence, Innovation, R&D and Chief Ethics Counsellor, Tata Chemicals; Dr. Debabrata Rautaray, Vice President and Chief Product Development & Innovation Officer, DCM Shriram Chemicals Innovation Centre; Dr. Prashant Puri, Head - R&D, Deepak Fertilizers and Petrochemicals Corporation (DFPCL); Dr. Deepak S Panmand, General Manager (R&D), Dhanuka Agritech; Dr. Mudassir. K. Munshi, Team Leader, Deepak Nitrite; and Dr. Manish M. Khandagale, Senior Field Application Specialist, Revvity Signals
For FY25, Revenue from operation grew 28.8 per cent YoY to Rs. 70.1 crore
For the full year FY25, net profit soared 12x to Rs 345 crore
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
Delivers robust earnings performance, successfully navigating a dynamic environment
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Subscribe To Our Newsletter & Stay Updated
